相关实验视频
Updated: May 10, 2025

09:44
A High-throughput, High-content, Liquid-based C. elegans Pathosystem
Published on: July 1, 2018
14.4K
探索在物种间和物种内部竞争中释放的生物活性分子:用于人类使用的新型抗寄生虫药物发现和设计的范例
1Department of Parasitology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, 10700, Thailand.
Current research in parasitology & vector-borne diseases
|April 28, 2025
概括
由于耐药性和毒性,迫切需要新的抗寄生虫药物. 从微生物竞争中探索生物活性分子提供了一个有前途的策略,用于发现有效打击寄生虫疾病的新药.
科学领域:
- 微生物学 微生物学
- 寄生虫学的寄生虫学
- 药物发现 药物发现 药物发现
背景情况:
- 现有的抗寄生虫药物面临诸如耐药性,高毒性和低疗效等挑战.
- 寄生病仍然对全球健康构成重大威胁,需要新的治疗干预措施.
- 发现新的抗寄生虫剂对于有效的疾病控制至关重要.
研究的目的:
- 审查从生物活性分子中识别新型抗寄生虫药物的策略,这些生物活性分子是在物种间和物种内部竞争中产生的.
- 突出微生物衍生化合物在抗寄生虫药物发现中的潜力.
- 讨论抗寄生虫药物开发当前的局限性和未来的方向.
主要方法:
- 文献综述侧重于有机体及其生物活性产品之间的竞争性相互作用.
- 分析微生物多样性作为新药候选药物的来源.
- 检查现有的抗寄生虫药物,它们的机制和局限性.
主要成果:
- 跨和内部竞争产生具有潜在抗寄生虫活性的生物活性分子.
- 微生物是发现新抗寄生虫剂的尚未开发的资源.
- 微生物衍生药物的历史成功 (例如,青素) 支持这种方法.
结论:
- 从微生物竞争中寻找分子是新的抗寄生虫药物发现的可行策略.
- 这种方法为克服当前抗寄生虫疗法的局限性提供了替代途径.
- 对微生物多样性的进一步研究可能会导致开发急需的抗寄生虫药物.
更多相关视频
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
2.4K
08:48Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
Published on: January 26, 2016
11.7K
相关概念视频
Drug Discovery: Overview
7.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.1K
Structure-Activity Relationships and Drug Design
429
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
429
Principles of Drug Action
5.6K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
5.6K